Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged >= 18 years

DSpace Repository

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged >= 18 years

Author: Kieninger, Dorothee; Sheldon, Eric; Lin, Wen-Yuan; Yu, Chong-Jen; Bayas, Jose M.; Gabor, Julian J.; Esen, Meral; Fernandez Roure, Jose Luis; Narejos Perez, Silvia; Sanchez, Carmen Alvarez; Feng, Yang; Claeys, Carine; Peeters, Mathieu; Innis, Bruce L.; Jain, Varsha
Tübinger Autor(en):
Gabor, Julian Justin
Esen, Meral
Published in: Bmc Infectious Diseases (2013), Bd. 13, Article 343
Verlagsangabe: Biomed Central Ltd
Language: English
Full text: http://dx.doi.org/10.1186/1471-2334-13-343
ISSN: 1471-2334
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)